ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,383, issued on May 6, was assigned to Rekovar Inc. (Irvine, Calif.).
"Integrated artificial intelligence based system for monitoring and remediating withdrawal symptoms" was invented by Shiva Sharareh (Laguna Niguel, Calif.), Abel Jimenez (Irvine, Calif.), Ariel Garcia (Vista, Calif.), Daryl Chau (Irvine, Calif.) and Neema Onbirbak (Laguna Niguel, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "In neonates or infants, the system identifies Neonatal Abstinence Syndrome (NAS) and in adult patients the system monitors for and identifies withdrawal and/or relapse symptoms. The system can be used for NAS babies in hospitals as well as in the home f...